Drugs / rV-CEA(6D)-TRICOM
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00081848 | Apr 2004 → Aug 2007 | liver and intrahepatic bile duct neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rV-CEA(6D)-TRICOM | “a "priming vaccine" called rV-CEA(6D)-TRICOM, made from vaccinia virus” NCT00081848 ↗ |
| Modality | Vaccine | “a "priming vaccine" called rV-CEA(6D)-TRICOM, made from vaccinia virus” NCT00081848 ↗ |
| Route | Subcutaneous | “rV-CEA(6D)/TRICOM, (1.2 x 10(8)) PFU subcutaneously (s.c.) day 1” NCT00081848 ↗ |